Home › NDC Lookup › RxCUI directory › RxCUI 1091133

Methylphenidate hydrochloride 2 MG/ML Oral Solution — RxCUI 1091133

RxNorm drug concept · Semantic clinical drug
RxCUI 1091133 Semantic clinical drug · SCD ● Current RxNorm concept 21 FDA products 23 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1091133
Official nameMethylphenidate hydrochloride 2 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmethylphenidate HCl 10 MG per 5 ML Oral Solution; methylphenidate HCl 10 MG in 5 mL Oral Solution; methylphenidate hydrochloride 10 MG per 5 ML Oral Solution
FDA products mapped21
Package NDCs mapped23
Reported Medicaid activity (SDUD)118,606 prescriptions · 49 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Methylphenidate Transdermal Patch: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Yes, location matters. Apply the patch to the hip area — not the waist, arm, or back. The clinical studies that established how well and how safely the patch works were done specif...
  • Where exactly do I put the patch and does it matter?
  • Water exposure — from bathing, swimming, or showering — can affect how well the patch sticks. If the patch partially or fully comes off, don't try to re-stick it with tape or adhes...
  • Can my child shower or swim while wearing the patch?
📖 Read our full Methylphenidate Transdermal Patch guide →

🕸️ Concept Web — How Methylphenidate hydrochloride 2 MG/ML Oral Solut... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Methylphenidate hydrochloride 2 MG/ML Oral Solution RxCUI 1091133

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Methylphenidate 6901
    • Methylphenidate hydrochloride 203188
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Methylin 261572
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Methylphenidate Oral Solution 476368
    • Methylphenidate hydrochloride Oral Solution 2649509
    • Methylphenidate Oral Liquid Product 1162890
    • Methylphenidate Oral Product 1163482
    • Methylphenidate hydrochloride Oral Liquid Product 2661150
    • Methylphenidate hydrochloride Oral Product 2661865
    • Methylphenidate Oral Solution [Methylin] 543272
    • Methylphenidate hydrochloride Oral Solution [Methylin] 2658701
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Methylphenidate hydrochloride 2 MG/ML SCDC · 1091132
  • Methylphenidate Oral Solution SCDF · 476368
  • Methylphenidate hydrochloride Oral Solution SCDFP · 2649509
  • Methylphenidate Oral Liquid Product SCDG · 1162890
  • Methylphenidate Oral Product SCDG · 1163482
  • Methylphenidate hydrochloride Oral Liquid Product SCDGP · 2661150
  • Methylphenidate hydrochloride Oral Product SCDGP · 2661865

Brand-Name Concepts

  • Methylphenidate hydrochloride 2 MG/ML Oral Solution [Methylin] SBD · 1091135
  • Methylphenidate hydrochloride 2 MG/ML [Methylin] SBDC · 1091134
  • Methylphenidate Oral Solution [Methylin] SBDF · 543272
  • Methylphenidate hydrochloride Oral Solution [Methylin] SBDFP · 2658701
  • Methylin Oral Liquid Product SBDG · 1176936
  • Methylin Oral Product SBDG · 1176937
  • Methylin BN · 261572

📦 FDA Products & Package NDCs

21 products · 23 package NDCs
23 package NDCs map to RxCUI 1091133 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
10702-0163-50 500 mL in 1 BOTTLE (10702-163-50) Methylphenidate KVK-Tech, Inc. 2017-01-23
10702-0164-50 500 mL in 1 BOTTLE (10702-164-50) Methylphenidate KVK-Tech, Inc. 2017-01-23
27808-0058-01 500 mL in 1 BOTTLE, PLASTIC (27808-058-01) Methylphenidate Hydrochloride Cranbury Pharmaceuticals, LLC 2015-03-04
27808-0059-01 500 mL in 1 BOTTLE, PLASTIC (27808-059-01) Methylphenidate Hydrochloride Cranbury Pharmaceuticals, LLC 2015-03-04
39328-0054-50 500 mL in 1 BOTTLE (39328-054-50) Methylphenidate HCl Patrin Pharma, Inc. 2020-04-23
39328-0154-50 500 mL in 1 BOTTLE (39328-154-50) Methylphenidate HCl Patrin Pharma, Inc. 2020-04-23
43386-0930-05 500 mL in 1 BOTTLE (43386-930-05) Methylphenidate Hydrochloride Lupin Pharmaceuticals,Inc. 2015-12-15
43386-0931-05 500 mL in 1 BOTTLE (43386-931-05) Methylphenidate Hydrochloride Lupin Pharmaceuticals,Inc. 2015-12-15
43602-0177-05 500 mL in 1 BOTTLE (43602-177-05) Methylphenidate Hydrochloride Ascent Pharmaceuticals, Inc. 2021-01-29
43602-0177-25 250 mL in 1 BOTTLE (43602-177-25) Methylphenidate Hydrochloride Ascent Pharmaceuticals, Inc. 2021-01-29
43602-0178-05 500 mL in 1 BOTTLE (43602-178-05) Methylphenidate Hydrochloride Ascent Pharmaceuticals, Inc. 2021-01-29
43602-0178-25 250 mL in 1 BOTTLE (43602-178-25) Methylphenidate Hydrochloride Ascent Pharmaceuticals, Inc. 2021-01-29
59630-0750-50 500 mL in 1 BOTTLE (59630-750-50) Methylin SHIONOGI INC. 2002-12-19
59630-0755-50 500 mL in 1 BOTTLE (59630-755-50) Methylin SHIONOGI INC. 2002-12-19
63629-1176-01 500 mL in 1 BOTTLE (63629-1176-1) Methylphenidate Hydrochloride Bryant Ranch Prepack 2021-06-29
67877-0602-91 500 mL in 1 BOTTLE (67877-602-91) Methylphenidate Hydrochloride Ascend Laboratories, LLC 2020-04-01
67877-0603-91 500 mL in 1 BOTTLE (67877-603-91) Methylphenidate Hydrochloride Ascend Laboratories, LLC 2020-04-01
70752-0131-14 500 mL in 1 BOTTLE, PLASTIC (70752-131-14) METHYLPHENIDATE HYDROCHLORIDE QUAGEN PHARMACEUTICALS LLC 2020-06-04
70752-0132-14 500 mL in 1 BOTTLE, PLASTIC (70752-132-14) METHYLPHENIDATE HYDROCHLORIDE QUAGEN PHARMACEUTICALS LLC 2020-06-04
71930-0024-52 500 mL in 1 BOTTLE (71930-024-52) Methylphenidate Hydrochloride Eywa Pharma Inc 2019-03-29
71930-0025-52 500 mL in 1 BOTTLE (71930-025-52) Methylphenidate Hydrochloride Eywa Pharma Inc 2019-03-29
72162-1993-05 500 mL in 1 BOTTLE (72162-1993-5) Methylphenidate Hydrochloride Bryant Ranch Prepack 2024-02-05
72162-2041-05 500 mL in 1 BOTTLE, PLASTIC (72162-2041-5) Methylphenidate Hydrochloride Bryant Ranch Prepack 2024-04-03
Observed labelers: Ascent Pharmaceuticals, Inc. (4) · Bryant Ranch Prepack (3) · Ascend Laboratories, LLC (2) · Cranbury Pharmaceuticals, LLC (2) · Eywa Pharma Inc (2) · KVK-Tech, Inc. (2) · +4 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.